Page last updated: 2024-08-24

fluorodeoxyglucose f18 and 19-iodocholesterol

fluorodeoxyglucose f18 has been researched along with 19-iodocholesterol in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	1 (16.67)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Klain, M; Mainolfi, C; Maurea, S; Salvatore, M; Ziviello, M	1
Lawson, MA	1
Caracò, C; Klain, M; Mainolfi, C; Maurea, S; Salvatore, M	1
Tenenbaum, F	1
Bertagna, X; Bertherat, J; Dousset, B; Ghander, C; Groussin, L; Legmann, P; Ragazzon, B; Richard, B; Silvera, S; Tenenbaum, F; Tissier, F	1
Alnaim, A; Aziz, TA; Bomanji, J; Chung, TT; Kurzawinski, TR; Riaz, S; Syed, R; Wan, S	1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and 19-iodocholesterol

Article	Year
[Adrenal incidentaloma and nuclear medicine examination]. Journal de radiologie, 2009, Volume: 90, Issue:3 Pt 2 Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals	2009

Article

Year

[Adrenal incidentaloma and nuclear medicine examination].

Journal de radiologie, 2009, Volume: 90, Issue:3 Pt 2

Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals

2009

Trials

1 trial(s) available for fluorodeoxyglucose f18 and 19-iodocholesterol

Article	Year
Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2004, Volume: 48, Issue:3 Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2004

Article

Year

Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2004, Volume: 48, Issue:3

Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity

2004

Other Studies

4 other study(ies) available for fluorodeoxyglucose f18 and 19-iodocholesterol

Article	Year
The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:6 Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity	2001
Role of molecular imaging in management of nonhypersecreting adrenal masses. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:6 Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity	2001
A concomitant false-negative ¹⁸F-FDG PET imaging in an adrenocortical carcinoma and a high uptake in a corresponding liver metastasis. The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:4 Topics: 19-Iodocholesterol; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution	2012
The value of 18F-FDG PET-CT and 131I-norcholesterol scintigraphy in the characterization of high-risk adrenal masses. Nuclear medicine communications, 2020, Volume: 41, Issue:3 Topics: 19-Iodocholesterol; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Young Adult	2020